| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Spectrin | 3.59e-04 | 23 | 114 | 3 | PF00435 | |
| Domain | Dynamin_central | 5.45e-04 | 6 | 114 | 2 | IPR000375 | |
| Domain | GOLGA6L | 5.45e-04 | 6 | 114 | 2 | IPR026737 | |
| Domain | GED | 5.45e-04 | 6 | 114 | 2 | SM00302 | |
| Domain | Dynamin_M | 5.45e-04 | 6 | 114 | 2 | PF01031 | |
| Domain | GED_dom | 5.45e-04 | 6 | 114 | 2 | IPR020850 | |
| Domain | GED | 5.45e-04 | 6 | 114 | 2 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 5.45e-04 | 6 | 114 | 2 | IPR019762 | |
| Domain | GED | 5.45e-04 | 6 | 114 | 2 | PF02212 | |
| Domain | GED | 5.45e-04 | 6 | 114 | 2 | IPR003130 | |
| Domain | - | 6.31e-04 | 64 | 114 | 4 | 3.40.50.1000 | |
| Domain | Spectrin_repeat | 7.21e-04 | 29 | 114 | 3 | IPR002017 | |
| Domain | G_DYNAMIN_1 | 7.60e-04 | 7 | 114 | 2 | PS00410 | |
| Domain | DYNc | 7.60e-04 | 7 | 114 | 2 | SM00053 | |
| Domain | Ubiquitin-rel_dom | 9.32e-04 | 184 | 114 | 6 | IPR029071 | |
| Domain | SPEC | 9.66e-04 | 32 | 114 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.66e-04 | 32 | 114 | 3 | IPR018159 | |
| Domain | BTK | 1.29e-03 | 9 | 114 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 1.29e-03 | 9 | 114 | 2 | IPR001562 | |
| Domain | BTK | 1.29e-03 | 9 | 114 | 2 | PF00779 | |
| Domain | ZF_BTK | 1.29e-03 | 9 | 114 | 2 | PS51113 | |
| Domain | HAD-like_dom | 1.39e-03 | 79 | 114 | 4 | IPR023214 | |
| Domain | MYB_LIKE | 1.60e-03 | 38 | 114 | 3 | PS50090 | |
| Domain | PDZ | 1.74e-03 | 141 | 114 | 5 | PF00595 | |
| Domain | PDZ | 2.15e-03 | 148 | 114 | 5 | SM00228 | |
| Domain | - | 2.27e-03 | 150 | 114 | 5 | 2.30.42.10 | |
| Domain | PDZ | 2.34e-03 | 151 | 114 | 5 | PS50106 | |
| Domain | - | 2.34e-03 | 12 | 114 | 2 | 3.40.50.1010 | |
| Domain | PDZ | 2.41e-03 | 152 | 114 | 5 | IPR001478 | |
| Domain | G_DYNAMIN_dom | 3.20e-03 | 14 | 114 | 2 | IPR030381 | |
| Domain | PIN_domain-like | 3.20e-03 | 14 | 114 | 2 | IPR029060 | |
| Domain | G_DYNAMIN_2 | 3.20e-03 | 14 | 114 | 2 | PS51718 | |
| Domain | WD40_repeat_CS | 3.34e-03 | 164 | 114 | 5 | IPR019775 | |
| Domain | SANT | 3.52e-03 | 50 | 114 | 3 | SM00717 | |
| Domain | Dynamin_GTPase | 3.68e-03 | 15 | 114 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 3.68e-03 | 15 | 114 | 2 | IPR022812 | |
| Domain | Dynamin_N | 3.68e-03 | 15 | 114 | 2 | PF00350 | |
| Domain | Glyco_hormone_CN | 3.68e-03 | 15 | 114 | 2 | IPR006208 | |
| Domain | Cys_knot | 3.68e-03 | 15 | 114 | 2 | PF00007 | |
| Domain | SANT/Myb | 3.94e-03 | 52 | 114 | 3 | IPR001005 | |
| Domain | GOLGA2L5 | 5.30e-03 | 18 | 114 | 2 | PF15070 | |
| Domain | CTCK_1 | 5.30e-03 | 18 | 114 | 2 | PS01185 | |
| Domain | Golgin_A | 5.30e-03 | 18 | 114 | 2 | IPR024858 | |
| Domain | P-loop_NTPase | DDX17 MYO7B SMC6 IFI44 MAGI3 DNM1L DDX51 AK9 TK2 RHOBTB2 KIFC3 MX1 | 5.62e-03 | 848 | 114 | 12 | IPR027417 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 DIP2B RASA3 UVSSA BARD1 MAGI3 BCR GMPS ZNF462 BPTF PPP4C WDR11 TBCK CSTF3 IGSF9 BOD1L1 NLGN2 RAPGEF2 KAT6B | 3.75e-07 | 1489 | 114 | 19 | 28611215 |
| Pubmed | MAGI3 RICTOR ZKSCAN5 ZNF462 PIKFYVE ALMS1 WDR11 SLITRK5 NLGN2 CDC5L EIF2AK1 | 7.20e-07 | 493 | 114 | 11 | 15368895 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DIP2B SPTAN1 MAGI3 DNM1L RICTOR BCR BMX AKAP9 ALMS1 TIMM50 BOD1L1 RAPGEF2 PCDH7 KLC3 | 9.27e-07 | 861 | 114 | 14 | 36931259 |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 1.29e-06 | 419 | 114 | 10 | 28700943 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FAM120B LRWD1 DDX17 RASA3 SPTAN1 RICTOR DDX51 URB2 TBL3 GTF3C5 GMPS UTP18 GRHPR WDR11 TIMM50 PRKDC CDC5L | 2.04e-06 | 1353 | 114 | 17 | 29467282 |
| Pubmed | DDX17 ANK2 BZW2 MAGI3 DNM1L RICTOR GMPS SLITRK5 BOD1L1 PRKDC PCDH7 TBCE | 3.84e-06 | 708 | 114 | 12 | 39231216 | |
| Pubmed | DDX17 SPTAN1 DNM1L TBL3 GTF3C5 GMPS TIMM50 CSTF3 PRKDC CDC5L ZW10 | 8.48e-06 | 638 | 114 | 11 | 33239621 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 24593181 | ||
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 9422767 | ||
| Pubmed | BPTF Maintains Chromatin Accessibility and the Self-Renewal Capacity of Mammary Gland Stem Cells. | 1.07e-05 | 2 | 114 | 2 | 28579392 | |
| Pubmed | BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor. | 1.07e-05 | 2 | 114 | 2 | 18071309 | |
| Pubmed | Dual oxidase 1-dependent MUC5AC mucin expression in cultured human airway epithelial cells. | 1.07e-05 | 2 | 114 | 2 | 15640347 | |
| Pubmed | 1.07e-05 | 2 | 114 | 2 | 23084358 | ||
| Pubmed | 1.18e-05 | 153 | 114 | 6 | 10718198 | ||
| Pubmed | Loss of Anks6 leads to YAP deficiency and liver abnormalities. | 2.70e-05 | 18 | 114 | 3 | 32886109 | |
| Pubmed | SMC6 DNM1L TBL3 GTF3C5 GMPS MED15 BPTF PPP4C CSTF3 HTATSF1 BOD1L1 PRKDC CDC5L | 2.92e-05 | 1014 | 114 | 13 | 32416067 | |
| Pubmed | PPP4R1 SZT2 SMC6 DNM1L RICTOR SPAG7 HAUS3 TBL3 GMPS SNX14 SLC7A6OS EIF2AK1 TBCE GABPB1 WDR48 | 2.96e-05 | 1327 | 114 | 15 | 32694731 | |
| Pubmed | 3.05e-05 | 54 | 114 | 4 | 35474131 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 3.14e-05 | 370 | 114 | 8 | 22922362 | |
| Pubmed | Golgi Phosphoprotein 3 Promotes Wls Recycling and Wnt Secretion in Glioma Progression. | 3.19e-05 | 3 | 114 | 2 | 29990993 | |
| Pubmed | Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. | 3.19e-05 | 3 | 114 | 2 | 26245375 | |
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 23691121 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 24307589 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 38424148 | ||
| Pubmed | 3.19e-05 | 3 | 114 | 2 | 27507813 | ||
| Pubmed | Wnt signaling regulates homeostasis of the periodontal ligament. | 3.19e-05 | 3 | 114 | 2 | 24410666 | |
| Pubmed | 3.34e-05 | 272 | 114 | 7 | 31010829 | ||
| Pubmed | 3.65e-05 | 378 | 114 | 8 | 34315543 | ||
| Pubmed | 3.67e-05 | 187 | 114 | 6 | 26460568 | ||
| Pubmed | PPP4R1 BZW2 SPTAN1 RICTOR GMPS PPP4C AKAP9 WDR11 TIMM50 CSTF3 CDC5L PCDH7 WDR48 | 4.13e-05 | 1049 | 114 | 13 | 27880917 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DDX17 SMC6 BARD1 DDX51 URB2 TBL3 GTF3C5 BPTF UTP18 PRKDC CDC5L | 4.18e-05 | 759 | 114 | 11 | 35915203 |
| Pubmed | 4.91e-05 | 197 | 114 | 6 | 36604605 | ||
| Pubmed | ATP13A4 LIN7C HECTD3 BARD1 DDX51 URB2 TBL3 GTF3C5 MED15 ANKRD36B | 4.95e-05 | 638 | 114 | 10 | 31182584 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DIP2B LRWD1 SPTAN1 RICTOR DDX51 PITPNM1 BPTF UTP18 PRKDC KAT6B PCDH7 | 4.98e-05 | 774 | 114 | 11 | 15302935 |
| Pubmed | DDX17 EFCAB6 SMC6 DNM1L RICTOR UTP18 WDR11 SLITRK5 PRKDC RAPGEF2 PCDH7 | 5.15e-05 | 777 | 114 | 11 | 35844135 | |
| Pubmed | 5.78e-05 | 650 | 114 | 10 | 38777146 | ||
| Pubmed | 6.14e-05 | 407 | 114 | 8 | 12693553 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 34931663 | ||
| Pubmed | Activating Hair Follicle Stem Cells via R-spondin2 to Stimulate Hair Growth. | 6.36e-05 | 4 | 114 | 2 | 27109869 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 15805470 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 25422448 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 24485452 | ||
| Pubmed | mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. | 6.36e-05 | 4 | 114 | 2 | 16221682 | |
| Pubmed | Endothelial Wnts control mammary epithelial patterning via fibroblast signaling. | 6.36e-05 | 4 | 114 | 2 | 33789106 | |
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 22773809 | ||
| Pubmed | 6.36e-05 | 4 | 114 | 2 | 34050174 | ||
| Pubmed | Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes. | 6.36e-05 | 4 | 114 | 2 | 14593108 | |
| Pubmed | Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. | 6.36e-05 | 4 | 114 | 2 | 10026142 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | LRWD1 DDX17 NT5C3A WLS TBL3 FBXL3 GTF3C5 GMPS PPP4C WDR11 TIMM50 PRKDC CDC5L WDR48 | 6.52e-05 | 1257 | 114 | 14 | 37317656 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX17 SPTAN1 SMC6 DNM1L URB2 TBL3 GTF3C5 UTP18 TIMM50 CSTF3 PNPLA8 BOD1L1 PRKDC TDRD6 CDC5L | 6.63e-05 | 1425 | 114 | 15 | 30948266 |
| Pubmed | NR2C1 LRWD1 DDX17 BZW2 GMFG SPAG7 GMPS MED15 BPTF CSTF3 PRKDC ZW10 GABPB1 | 6.87e-05 | 1103 | 114 | 13 | 34189442 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 7.16e-05 | 67 | 114 | 4 | 21875946 | |
| Pubmed | DDX17 SMC6 DNM1L GTF3C5 AXIN2 WDR11 TIMM50 HTATSF1 BOD1L1 PRKDC CDC5L | 7.38e-05 | 809 | 114 | 11 | 32129710 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | HECTD3 SOX30 BARD1 RICTOR GTF3C5 ALMS1 GRHPR CDC5L EIF2AK1 WDR48 | 7.43e-05 | 670 | 114 | 10 | 22990118 |
| Pubmed | 7.97e-05 | 215 | 114 | 6 | 30462309 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 9.04e-05 | 220 | 114 | 6 | 35785414 | |
| Pubmed | 1.02e-04 | 225 | 114 | 6 | 12168954 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 29874594 | ||
| Pubmed | SUMO-Modified FADD Recruits Cytosolic Drp1 and Caspase-10 to Mitochondria for Regulated Necrosis. | 1.06e-04 | 5 | 114 | 2 | 27799292 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 18347064 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 24315444 | ||
| Pubmed | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | 1.06e-04 | 5 | 114 | 2 | 26626481 | |
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 22632975 | ||
| Pubmed | 1.06e-04 | 5 | 114 | 2 | 33399538 | ||
| Pubmed | Repression of MAP3K1 expression and JNK activity by canonical Wnt signaling. | 1.06e-04 | 5 | 114 | 2 | 29787744 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | LRWD1 DDX17 SMC6 HAUS3 FBXL3 GTF3C5 CCN1 TIMM50 HTATSF1 PRKDC KIFC3 CDC5L ZW10 | 1.09e-04 | 1155 | 114 | 13 | 20360068 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DDX17 BZW2 SMC6 GOLPH3 BCR GTF3C5 MED15 MARF1 EIF2AK1 ZW10 MUC5AC KLC3 TBCE WDR48 | 1.10e-04 | 1321 | 114 | 14 | 27173435 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.17e-04 | 332 | 114 | 7 | 32786267 | |
| Pubmed | DIP2B DDX17 BZW2 DNM1L DDX51 BCR MED15 SYNE3 WDR11 MARF1 PRKDC CDC5L ZW10 | 1.22e-04 | 1168 | 114 | 13 | 19946888 | |
| Pubmed | 1.45e-04 | 151 | 114 | 5 | 17043677 | ||
| Pubmed | Fyn Regulates Binding Partners of Cyclic-AMP Dependent Protein Kinase A. | 1.57e-04 | 82 | 114 | 4 | 30274258 | |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 16999686 | ||
| Pubmed | Chromophore supply modulates cone function and survival in retinitis pigmentosa mouse models. | 1.58e-04 | 6 | 114 | 2 | 37252956 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 1.58e-04 | 6 | 114 | 2 | 23728480 | |
| Pubmed | LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis. | 1.58e-04 | 6 | 114 | 2 | 30224759 | |
| Pubmed | 1.58e-04 | 6 | 114 | 2 | 36931279 | ||
| Pubmed | Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. | 1.58e-04 | 6 | 114 | 2 | 16687515 | |
| Pubmed | 1.63e-04 | 469 | 114 | 8 | 27634302 | ||
| Pubmed | 1.84e-04 | 159 | 114 | 5 | 22751105 | ||
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 2.21e-04 | 7 | 114 | 2 | 7495297 | |
| Pubmed | Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells. | 2.21e-04 | 7 | 114 | 2 | 29420258 | |
| Pubmed | 2.21e-04 | 7 | 114 | 2 | 33480845 | ||
| Pubmed | 2.31e-04 | 494 | 114 | 8 | 26831064 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NR2C1 DDX17 ANK2 DNM1L SPAG7 GMPS ALMS1 HTATSF1 BOD1L1 PRKDC CDC5L | 2.57e-04 | 934 | 114 | 11 | 33916271 |
| Pubmed | Bridging expressed sequence alignments through targeted cDNA sequencing. | 2.94e-04 | 8 | 114 | 2 | 15028280 | |
| Pubmed | A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. | 2.94e-04 | 8 | 114 | 2 | 18614045 | |
| Pubmed | Activated mTORC1 promotes long-term cone survival in retinitis pigmentosa mice. | 2.94e-04 | 8 | 114 | 2 | 25798619 | |
| Pubmed | Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity. | 2.94e-04 | 8 | 114 | 2 | 39047106 | |
| Pubmed | 2.94e-04 | 8 | 114 | 2 | 36002185 | ||
| Pubmed | Wnt signaling though beta-catenin is required for prostate lineage specification. | 2.94e-04 | 8 | 114 | 2 | 22960283 | |
| Pubmed | 2.98e-04 | 513 | 114 | 8 | 25798074 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NR2C1 DDX17 SMC6 TBL3 BPTF MARF1 CSTF3 HTATSF1 BOD1L1 PRKDC CDC5L | 3.08e-04 | 954 | 114 | 11 | 36373674 |
| Pubmed | 3.09e-04 | 653 | 114 | 9 | 33742100 | ||
| Pubmed | LRWD1 DDX17 LIN7C SPTAN1 DNM1L URB2 TBL3 GMPS TBC1D13 BPTF CCN1 BOD1L1 PRKDC | 3.36e-04 | 1297 | 114 | 13 | 33545068 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.39e-04 | 281 | 114 | 6 | 28706196 | |
| Pubmed | ANK2 HECTD3 SPTAN1 RICTOR TBL3 UTP18 SYNE3 AKAP9 WDR11 TIMM50 HTATSF1 PNPLA8 CDC5L PCDH7 | 3.70e-04 | 1487 | 114 | 14 | 33957083 | |
| Pubmed | 3.77e-04 | 103 | 114 | 4 | 10819331 | ||
| Pubmed | 3.91e-04 | 104 | 114 | 4 | 9205841 | ||
| Pubmed | 4.67e-04 | 549 | 114 | 8 | 38280479 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 4.71e-04 | 10 | 114 | 2 | 22159418 | |
| GeneFamily | WD repeat domain containing|UTPB complex | 2.26e-04 | 6 | 71 | 2 | 1225 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.15e-04 | 7 | 71 | 2 | 1113 | |
| GeneFamily | PDZ domain containing | 3.28e-04 | 152 | 71 | 5 | 1220 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.18e-03 | 53 | 71 | 3 | 532 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#4_top-relative-expression-ranked_200 | 2.35e-05 | 11 | 113 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 NR2C1 EFCAB6 HAUS3 ZKSCAN5 GMPS AKAP9 ALMS1 PRKDC RAPGEF2 GABPB1 | 4.17e-05 | 469 | 113 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.74e-07 | 177 | 114 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.50e-07 | 200 | 114 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.50e-07 | 200 | 114 | 7 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.79e-06 | 142 | 114 | 6 | 0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-06 | 184 | 114 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.74e-06 | 187 | 114 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.02e-05 | 192 | 114 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.02e-05 | 192 | 114 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-05 | 192 | 114 | 6 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 193 | 114 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.08e-05 | 194 | 114 | 6 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 199 | 114 | 6 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.25e-05 | 199 | 114 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 199 | 114 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.25e-05 | 199 | 114 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.83e-05 | 138 | 114 | 5 | 97f5dc17522462133e582b508ad0ef036e656872 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.83e-05 | 138 | 114 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 153 | 114 | 5 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 153 | 114 | 5 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-05 | 153 | 114 | 5 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.09e-05 | 156 | 114 | 5 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.57e-05 | 159 | 114 | 5 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-05 | 163 | 114 | 5 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 164 | 114 | 5 | 85f53d184fa70e3eb1af655807f32b17ddbfb304 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-A_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 164 | 114 | 5 | 144ba070a1ede71684224cc6d4ead3b7e6a7b4c6 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 7.03e-05 | 167 | 114 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.23e-05 | 168 | 114 | 5 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.76e-05 | 175 | 114 | 5 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.00e-04 | 180 | 114 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-04 | 183 | 114 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 184 | 114 | 5 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.11e-04 | 184 | 114 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.11e-04 | 184 | 114 | 5 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 1.14e-04 | 185 | 114 | 5 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.17e-04 | 186 | 114 | 5 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-04 | 187 | 114 | 5 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 187 | 114 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.23e-04 | 188 | 114 | 5 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-04 | 190 | 114 | 5 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.29e-04 | 190 | 114 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.29e-04 | 190 | 114 | 5 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-04 | 191 | 114 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-04 | 191 | 114 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.32e-04 | 191 | 114 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-04 | 191 | 114 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 1.32e-04 | 191 | 114 | 5 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.35e-04 | 192 | 114 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.35e-04 | 192 | 114 | 5 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.35e-04 | 192 | 114 | 5 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-04 | 192 | 114 | 5 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.35e-04 | 192 | 114 | 5 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 193 | 114 | 5 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 193 | 114 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 193 | 114 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-04 | 193 | 114 | 5 | 44839a606ae2f8e37421bda46d588189e1c943d2 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.42e-04 | 194 | 114 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-04 | 195 | 114 | 5 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.45e-04 | 195 | 114 | 5 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 196 | 114 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.49e-04 | 196 | 114 | 5 | b74dbdfc8d9b85d7cae5c6a49b56347b15ce16e1 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 1.49e-04 | 196 | 114 | 5 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | distal-1-Epithelial-Alveolar_Epithelial_Type_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.53e-04 | 197 | 114 | 5 | d44b7dc7c6416ed9466889374c3ae39f43ac8bb6 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.53e-04 | 197 | 114 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.56e-04 | 198 | 114 | 5 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 198 | 114 | 5 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.56e-04 | 198 | 114 | 5 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.60e-04 | 199 | 114 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 199 | 114 | 5 | f4fdf94c561dca35bb17766d908c5030655f43eb | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | medial-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.60e-04 | 199 | 114 | 5 | 95aae608fa35a9c82b12c6f18937ce636750ca44 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.60e-04 | 199 | 114 | 5 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-04 | 199 | 114 | 5 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.60e-04 | 199 | 114 | 5 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-04 | 199 | 114 | 5 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-04 | 199 | 114 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | medial-mesenchymal-Myofibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.60e-04 | 199 | 114 | 5 | e25acdb5809aaff631cb06dbe4c7e59549a0bdb9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.60e-04 | 199 | 114 | 5 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | medial-mesenchymal-Myofibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.60e-04 | 199 | 114 | 5 | 9ebf4822ff9fa08574edec5dbf4f2a1488f34b1d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 199 | 114 | 5 | c0fe99ed906d0eb99cccdab9a1fa32c17b3542e7 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.60e-04 | 199 | 114 | 5 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.64e-04 | 200 | 114 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-04 | 200 | 114 | 5 | 7bd76884fcffdbd9b8d24f5b6b5187ad3963da5f | |
| ToppCell | severe-B_intermediate|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.64e-04 | 200 | 114 | 5 | 6d0ac3d00400dd5657ee266f7b885381bf790ce1 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.64e-04 | 200 | 114 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 1.64e-04 | 200 | 114 | 5 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-04 | 200 | 114 | 5 | af57f837eb7f988d24fc4612d16d68121498f0b0 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 1.64e-04 | 200 | 114 | 5 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-04 | 200 | 114 | 5 | cbe3e107ac16c17687d73ebb04c39d51aba1fa98 | |
| ToppCell | proximal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.64e-04 | 200 | 114 | 5 | 9c7859659843b1566bdf623b269b5e166c89d38c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 1.64e-04 | 200 | 114 | 5 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 1.64e-04 | 200 | 114 | 5 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 111 | 114 | 4 | a1b7940c6fa0e5a58aa4798b604469d79f33fa44 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 111 | 114 | 4 | d1ec8e8e9adb11511b4ef363cc6f99286e2cc842 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 111 | 114 | 4 | 567e5ac2c78d45db207067f0f152bb24ed048c50 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 111 | 114 | 4 | fd7aa25e83a0d762969e3966a658652da40c490e | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 111 | 114 | 4 | d48561078c387ac856c1c30e3d7a3e75ebde942e | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A | 5.17e-06 | 193 | 112 | 8 | 5758_DN | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A | 6.01e-06 | 197 | 112 | 8 | 6570_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 6.47e-06 | 199 | 112 | 8 | 5509_UP | |
| Drug | 5186223; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 6.71e-06 | 200 | 112 | 8 | 885_UP | |
| Disease | Global developmental delay | 1.38e-04 | 133 | 109 | 5 | C0557874 | |
| Disease | cytochrome c oxidase assembly factor 3 homolog, mitochondrial measurement | 3.73e-04 | 8 | 109 | 2 | EFO_0801513 | |
| Disease | Adenocarcinoma of large intestine | 4.51e-04 | 96 | 109 | 4 | C1319315 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 4.79e-04 | 9 | 109 | 2 | EFO_0801514 | |
| Disease | RNA-binding protein 24 measurement | 4.79e-04 | 9 | 109 | 2 | EFO_0802030 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 5.97e-04 | 10 | 109 | 2 | EFO_0801535 | |
| Disease | guanylate-binding protein 6 measurement | 7.28e-04 | 11 | 109 | 2 | EFO_0801662 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.03e-03 | 13 | 109 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | vascular endothelial growth factor measurement | 1.18e-03 | 56 | 109 | 3 | EFO_0004762 | |
| Disease | Romano-Ward Syndrome | 1.57e-03 | 16 | 109 | 2 | C0035828 | |
| Disease | Benign neoplasm of stomach | 1.77e-03 | 17 | 109 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.77e-03 | 17 | 109 | 2 | C0496905 | |
| Disease | alpha-L-iduronidase measurement | 1.77e-03 | 17 | 109 | 2 | EFO_0020139 | |
| Disease | Carcinoma in situ of stomach | 1.77e-03 | 17 | 109 | 2 | C0154060 | |
| Disease | blood metabolite measurement | 2.22e-03 | 19 | 109 | 2 | EFO_0005664 | |
| Disease | lung cancer (is_implicated_in) | 2.63e-03 | 74 | 109 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | Stomach Carcinoma | 2.71e-03 | 21 | 109 | 2 | C0699791 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.78e-03 | 157 | 109 | 4 | DOID:14330 (implicated_via_orthology) | |
| Disease | progression free survival, ovarian serous carcinoma | 2.98e-03 | 22 | 109 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Brugada Syndrome (disorder) | 3.54e-03 | 24 | 109 | 2 | C1142166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DDLPTVLKCARLVER | 1416 | Q14146 | |
| RIKNPTRVEEIICGL | 61 | Q9H0P0 | |
| DPCIQTIDEIRRQIR | 286 | Q6PI77 | |
| ELQERLSQECPIKEV | 261 | Q9Y6E2 | |
| GREICLREKTPEVID | 906 | A6H8Y1 | |
| EKEQVSLRCRELEII | 986 | Q99996 | |
| SAIPRRLECLKEDVQ | 761 | Q99459 | |
| RRKVCEQEEKYEIPE | 641 | Q99728 | |
| IKRLEEPSLRCVELV | 421 | O00429 | |
| KVPYIVRQCVEEIER | 1066 | P11274 | |
| EIRRLICGPNTIDVE | 176 | Q4VNC1 | |
| RCVEKVNLEEQTPVE | 61 | P51813 | |
| PECRLVKETRICEVR | 256 | O00622 | |
| CSERVAELQRKPTRE | 436 | Q8TCU4 | |
| ARCLEELQRQEPSVE | 806 | O94983 | |
| QLEEACRRLAEVSKP | 696 | Q9Y2T1 | |
| LCDREDRTPLIKAVQ | 81 | Q8N2N9 | |
| LVRQDPRFEICVEVI | 391 | P20711 | |
| RTREQDVEVLEPLKC | 1446 | Q12830 | |
| DSVQCERKPIEVSRE | 181 | P13056 | |
| EVCREKQEAAVPLVR | 326 | Q14644 | |
| CEIEVEEDGRKPVLR | 1176 | Q8WYB5 | |
| DVRLDQPQKRRVCEV | 471 | Q9UFC0 | |
| PEDLEKKRICRIITR | 1131 | Q01484 | |
| VEVPEVIKDLCRRAS | 941 | Q9NRD9 | |
| KVLCEAESRVPVEEI | 31 | Q8WTU0 | |
| REVIFEDVLLRRPKC | 331 | Q9NUD7 | |
| EPVRLERDICRAIEL | 6 | Q9NUP9 | |
| PVIEESLRVQICEKA | 1146 | Q5TCQ9 | |
| VVCEVDPELTEKLRK | 6 | O60234 | |
| EREKLCRIVIIDDSL | 1956 | Q5SZK8 | |
| PAKRQCIEIIENRVE | 326 | Q06547 | |
| TSERRIDREKLPQCQ | 86 | O60245 | |
| VKCDRDEIQLILPTR | 456 | P35913 | |
| EIFRRCKIPNTVEEA | 641 | Q12996 | |
| TCVVVAEERPRVALQ | 1281 | Q9P265 | |
| APVVCTRKRRLEDDE | 656 | Q96RN5 | |
| EAEIRECLEKVVPQA | 601 | Q8NG66 | |
| REQEERLCEQEKLPG | 321 | A6NEY3 | |
| LREQEERLCEQEKLP | 306 | A6NEF3 | |
| ERLCEQEKLPGQERL | 311 | A6NEF3 | |
| ERLCEQEKLPGQERL | 346 | H0YKK7 | |
| EPLCQRALEIREKVL | 311 | Q6P597 | |
| IIRSGEKICRRPEEI | 2146 | P98088 | |
| EKICRRPEEITRLQC | 2151 | P98088 | |
| NIIRSGEKICRRPEE | 3251 | P98088 | |
| GEKICRRPEEITRLQ | 3256 | P98088 | |
| NIIRSGEKICRRPEE | 4656 | P98088 | |
| GEKICRRPEEITRLQ | 4661 | P98088 | |
| RCREEEKVIPLEYLE | 196 | O00142 | |
| IITELCRNVRTPDLD | 901 | Q6R327 | |
| IEPKICREDLTDAIR | 371 | A8MWY0 | |
| PLVLNEIREDLRVEC | 281 | O43719 | |
| VVREPADREQLCRAK | 76 | Q9H158 | |
| VKRQVERSEICTEEP | 676 | Q8NFC6 | |
| REETKFTCIDPIVLQ | 716 | Q9Y2I7 | |
| VEERLREKCQNPAEL | 451 | Q9UFP1 | |
| LIRRVNEDLLEPVSC | 61 | P32927 | |
| KGDLIEIERCEPVRS | 356 | Q8TCB0 | |
| EIERCEPVRSKLEEV | 361 | Q8TCB0 | |
| NRELECIREIKERVG | 221 | P49915 | |
| AKERVRQDPCEDISR | 131 | Q9BQI3 | |
| RQDPCEDISRIQKIR | 136 | Q9BQI3 | |
| CRTLRELEIQVGEKV | 156 | Q5THR3 | |
| VRDKTEESCPILRIE | 26 | Q14993 | |
| NCVRRNVTEDLVPIE | 186 | Q8N8A6 | |
| PLDEELIRIAERCKN | 346 | Q9UKT7 | |
| APRERVIDLVRSCKE | 131 | Q14CM0 | |
| DVCAQDERSKRILPL | 726 | P10643 | |
| TTCRRLPEAIEEVKN | 121 | Q9UBQ7 | |
| KRVRQLLDLDPEVEC | 266 | Q9H4A6 | |
| PSICDNQEILEERRL | 246 | Q68CZ6 | |
| CIPKRERTQDEIERT | 1246 | Q9Y4F3 | |
| NCTKEEVERLLPTRQ | 96 | Q92851 | |
| PQIRDLERGVEICIA | 286 | Q92841 | |
| VEVEIQRLLGKVCDR | 386 | Q86VB7 | |
| VECLRRKPSRELVDQ | 326 | Q8NFZ4 | |
| EPEIQVRRLDTLLAC | 686 | Q96EK7 | |
| PSKEEREALVEECNR | 256 | P35680 | |
| RRTTDPKLCITRVEE | 371 | Q9NP80 | |
| REEEFEQLTQVIRCP | 2326 | Q5T011 | |
| CIRVEALPILEEQIA | 56 | Q5TCS8 | |
| NRLRLEEDKPAVERC | 76 | Q9Y5J1 | |
| LEAAPEKDTVVRCLR | 431 | Q2YD98 | |
| RRDVCDIPLAIVDLK | 1671 | O60522 | |
| QELIERFDVETKVCP | 161 | Q8TF05 | |
| RFDVETKVCPVLIEL | 166 | Q8TF05 | |
| CVPVANKRDTRSIEE | 191 | O75391 | |
| ETEKICQLEPEGRVR | 46 | Q6ZMZ3 | |
| CQLEPEGRVRVDLVL | 51 | Q6ZMZ3 | |
| SRILQETVKELAPRC | 871 | Q2TB90 | |
| RRCEAELQELRTKPA | 151 | Q9BVG8 | |
| KEREEIECIEIQENP | 826 | Q6ZW05 | |
| EDPLCADVILVLQER | 261 | Q9BYZ6 | |
| NRDPEEVKIICQRRS | 2326 | Q9NRC6 | |
| VIKTEEPERLLEDCR | 211 | O94993 | |
| PDVILCNSVELIRER | 161 | Q96CW6 | |
| RQVIEKERPQLAECE | 876 | O00562 | |
| IVRDCLEKDPIDRTD | 106 | Q9Y4G8 | |
| VKDISCLNRDPARVV | 231 | Q3ZCQ8 | |
| LRNPDIRVLICEEKA | 281 | Q8TAF3 | |
| LPRVEVILDCSDRQK | 281 | Q9UMS6 | |
| LLERIARKPTVCESE | 1681 | Q15772 | |
| DEVSKQELCPRRLIS | 276 | O94991 | |
| KERIPVFCIDVERND | 586 | Q9Y5W7 | |
| KTLNKCEILPEERRR | 366 | Q15813 | |
| IQAIRRDPEACEKLE | 686 | Q12788 | |
| DPVRCNSLEEIKALR | 2116 | Q13813 | |
| RQICPERIEVEKSAS | 851 | Q96SB8 | |
| LQIDKDVRRLCPDIS | 121 | Q9NVG8 | |
| PEIDIERCVRESINL | 686 | Q8TEA7 | |
| LEVQELEPVTLRCVA | 146 | Q9P2J2 | |
| LVEFCREILPEKQAE | 626 | P78527 | |
| KREILEDVRNSPCVS | 611 | O60290 | |
| LKCENVLLSPDERRV | 136 | Q9BXA6 | |
| CKELPAEVVERSILE | 216 | Q96JM2 | |
| VCTNPVDRKVEEELR | 241 | Q9Y5Q8 | |
| CDKIRDIEEAIPREI | 71 | Q5T9L3 | |
| AKVRLNPEECADVLR | 1096 | Q9BZH6 | |
| IEQLRRCELIKESEV | 11 | P60510 | |
| ELEERRQQIVACPDV | 131 | Q9Y2L8 | |
| REPEEVERTEEKVPC | 1226 | Q9H0D2 | |
| RLTRRVEEIKGEVCN | 26 | O43264 | |
| LPIIEIRIVECRDDG | 346 | Q5T447 | |
| EEKVRPCIDLIDSLR | 46 | P20591 | |
| LLEKSRVCRQAPEER | 236 | Q6PIF6 |